22Mar
HHS Declares Liability Immunity for Certain COVID-19 “Countermeasures”; Response Act Expands Protections for Mask Makers
Earlier this week, we discussed current trends and future implications of COVID-19 on businesses operating in the products arena, noting the most direct impact so far on the pharmaceutical and medical device spaces. Recognizing the potential...
By:
Butler Snow LLP
Related
Based on the public filing, the Bureau asserted that Sterling was engaged in the business of providi...
Read More >
Over thirty-five years ago, the NLRB held that an employer may not prohibit a union organizer’s acc...
Read More >
Drug testing has been a staple of the hiring process for decades, helping employers across industrie...
Read More >
On Friday, January 10, the Department of Justice’s Antitrust Division and the Federal Trade Commiss...
Read More >
A new retirement savings law passed as part of the 2019 spending bill and signed by President Trump ...
Read More >
With data privacy issues constantly in the news, what do businesses need to know about handling pers...
Read More >